CANNARA BIOTECH INC (LOVE.CA) Stock Fundamental Analysis
Canada - TSX-V:LOVE - CA13765U2002 - Common Stock
1.72 CAD
+0.06 (+3.61%)
Overall LOVE gets a fundamental rating of 6 out of 10. We evaluated LOVE against 3 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for LOVE as it has an excellent financial health rating, but there are worries on the profitability. LOVE is evaluated to be cheap and growing strongly. This does not happen too often!
1. Profitability
1.1 Basic Checks
LOVE had positive earnings in the past year.
In the past year LOVE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LOVE reported negative net income in multiple years.
In multiple years LOVE reported negative operating cash flow during the last 5 years.
1.2 Ratios
LOVE has a better Return On Assets (9.12%) than 100.00% of its industry peers.
With an excellent Return On Equity value of 15.74%, LOVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 15.74% | ||
| ROIC | N/A |
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LOVE has a better Profit Margin (15.15%) than 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 14.02%, LOVE is doing worse than 66.67% of the companies in the same industry.
LOVE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 15.15% | ||
| GM | 14.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
2. Health
2.1 Basic Checks
LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOVE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for LOVE has been increased compared to 5 years ago.
The debt/assets ratio for LOVE has been reduced compared to a year ago.
2.2 Solvency
LOVE has an Altman-Z score of 2.06. This is not the best score and indicates that LOVE is in the grey zone with still only limited risk for bankruptcy at the moment.
LOVE's Altman-Z score of 2.06 is fine compared to the rest of the industry. LOVE outperforms 66.67% of its industry peers.
LOVE has a debt to FCF ratio of 2.92. This is a good value and a sign of high solvency as LOVE would need 2.92 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.92, LOVE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
LOVE has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
LOVE has a Debt to Equity ratio of 0.41. This is amongst the best in the industry. LOVE outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 2.92 | ||
| Altman-Z | 2.06 |
ROIC/WACCN/A
WACC7.15%
2.3 Liquidity
A Current Ratio of 2.43 indicates that LOVE has no problem at all paying its short term obligations.
LOVE's Current ratio of 2.43 is fine compared to the rest of the industry. LOVE outperforms 66.67% of its industry peers.
LOVE has a Quick Ratio of 1.01. This is a normal value and indicates that LOVE is financially healthy and should not expect problems in meeting its short term obligations.
LOVE has a better Quick ratio (1.01) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.43 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
LOVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 189.86%, which is quite impressive.
Looking at the last year, LOVE shows a very strong growth in Revenue. The Revenue has grown by 33.04%.
Measured over the past years, LOVE shows a very strong growth in Revenue. The Revenue has been growing by 108.26% on average per year.
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.26%
Revenue 1Y (TTM)33.04%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%39.85%
3.2 Future
The Earnings Per Share is expected to grow by 42.03% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.04% on average over the next years. This is quite good.
EPS Next Y43.26%
EPS Next 2Y51.4%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue Next Year27.9%
Revenue Next 2Y22.09%
Revenue Next 3Y19.04%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
LOVE is valuated reasonably with a Price/Earnings ratio of 10.12.
Based on the Price/Earnings ratio, LOVE is valued cheaper than 100.00% of the companies in the same industry.
LOVE is valuated cheaply when we compare the Price/Earnings ratio to 25.45, which is the current average of the S&P500 Index.
LOVE is valuated reasonably with a Price/Forward Earnings ratio of 10.64.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LOVE indicates a rather cheap valuation: LOVE is cheaper than 100.00% of the companies listed in the same industry.
LOVE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.12 | ||
| Fwd PE | 10.64 |
4.2 Price Multiples
LOVE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LOVE is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.04 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LOVE's earnings are expected to grow with 42.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y51.4%
EPS Next 3Y42.03%
5. Dividend
5.1 Amount
LOVE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:LOVE (11/21/2025, 7:00:00 PM)
1.72
+0.06 (+3.61%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners27.72%
Ins Owner ChangeN/A
Market Cap163.23M
Revenue(TTM)102.43M
Net Income(TTM)15.52M
Analysts80
Price Target3.06 (77.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.12 | ||
| Fwd PE | 10.64 | ||
| P/S | 1.59 | ||
| P/FCF | 10.04 | ||
| P/OCF | 8.01 | ||
| P/B | 1.66 | ||
| P/tB | 1.66 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.17
EY9.88%
EPS(NY)0.16
Fwd EY9.4%
FCF(TTM)0.17
FCFY9.96%
OCF(TTM)0.21
OCFY12.48%
SpS1.08
BVpS1.04
TBVpS1.04
PEG (NY)0.23
PEG (5Y)N/A
Graham Number1.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 15.74% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 15.15% | ||
| GM | 14.02% | ||
| FCFM | 15.87% |
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
F-Score8
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 2.92 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 66.23% | ||
| Cap/Sales | 4.02% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 104.74% | ||
| Current Ratio | 2.43 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 2.06 |
F-Score8
WACC7.15%
ROIC/WACCN/A
Cap/Depr(3y)228.25%
Cap/Depr(5y)410.31%
Cap/Sales(3y)22.24%
Cap/Sales(5y)120%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.26%
EPS Next Y43.26%
EPS Next 2Y51.4%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue 1Y (TTM)33.04%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%39.85%
Revenue Next Year27.9%
Revenue Next 2Y22.09%
Revenue Next 3Y19.04%
Revenue Next 5YN/A
EBIT growth 1Y33.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y60.25%
EBIT Next 5YN/A
FCF growth 1Y228.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3771.44%
OCF growth 3YN/A
OCF growth 5YN/A
CANNARA BIOTECH INC / LOVE.CA FAQ
What is the fundamental rating for LOVE stock?
ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA.
What is the valuation status for LOVE stock?
ChartMill assigns a valuation rating of 8 / 10 to CANNARA BIOTECH INC (LOVE.CA). This can be considered as Undervalued.
What is the profitability of LOVE stock?
CANNARA BIOTECH INC (LOVE.CA) has a profitability rating of 3 / 10.
What is the financial health of CANNARA BIOTECH INC (LOVE.CA) stock?
The financial health rating of CANNARA BIOTECH INC (LOVE.CA) is 7 / 10.
What is the earnings growth outlook for CANNARA BIOTECH INC?
The Earnings per Share (EPS) of CANNARA BIOTECH INC (LOVE.CA) is expected to grow by 43.26% in the next year.